Catalyst Pharmaceuticals Inc. stock falls Thursday, underperforms market

Shares of Catalyst Pharmaceuticals Inc. CPRX, -1.00% slipped 1.00% to $11.86 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, +1.02% rising 1.02% to 13,238.52 and the Dow Jones Industrial Average DJIA, +0.50% rising 0.50% to 33,833.61.

This was the stock's second consecutive day of losses.

Catalyst Pharmaceuticals Inc. closed $10.25 below its 52-week high ($22.11), which the company reached on January 13th.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson JNJ, +1.10% rose 1.10% to $160.26, Pfizer Inc. PFE, +0.51% rose 0.51% to $39.09, and Abbott Laboratories ABT, -0.87% fell 0.87% to $100.78.

Trading volume (1.2 M) remained 691,885 below its 50-day average volume of 1.9 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Cattle futures have climbed to their highest prices on record as drought conditions in the southwestern United States devastated the animals’ feeding grounds, contributing to a drop in the size of the domestic cattle herd to its smallest in eight years.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy.